What you should know:
1. Takeda spun off several of its non-core business lines after closing its deal for Shire in 2019. The company has committed to selling $10 billion of its non-core assets.
2. Takeda acquired Shire for $62 billion, which made it one of the most indebted companies in the world.
3. Blackstone acquired a portfolio of drugs that made a reported $567 million (60 billion yen) in 2019.
More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs
